Literature DB >> 12533098

The fragile X premutation presenting as essential tremor.

Maureen A Leehey1, Renato P Munhoz, Anthony E Lang, James A Brunberg, Jim Grigsby, Claudia Greco, Sebastian Jacquemont, Flora Tassone, A M Lozano, Paul J Hagerman, Randi J Hagerman.   

Abstract

CONTEXT: The fragile X premutation has recently been reported to be associated with a neurodegenerative syndrome, chiefly characterized by intention tremor, gait ataxia, and executive cognitive deficits in men older than 50 years. Essential tremor is a frequent cause of tremor in elderly patients and in some cases is associated with impaired tandem gait and cognitive deficits.
OBJECTIVE: To describe 2 fragile X carriers whose clinical presentation mimicked essential tremor.
DESIGN: The 2 patients described herein underwent neurologic examinations by experienced movement disorders neurologists, magnetic resonance imaging, and fragile X gene, messenger RNA, and protein analyses. One underwent detailed neuropsychological testing.
SETTING: Patients were studied at 2 large university movement disorders clinics. PATIENTS: Both patients were white men older than 50 years who had been diagnosed as having essential tremor and then found to be fragile X carriers.
RESULTS: Besides disabling intention tremor, the 2 patients had impaired tandem, generalized brain atrophy, and unusual bilateral T2 middle cerebellar hyperintensities on magnetic resonance imaging. The patient who underwent neuropsychological testing had frontal executive deficits. Both patients had elevated fragile X mental retardation gene 1 messenger RNA and reduced fragile X mental retardation 1 protein levels.
CONCLUSION: The fragile X carrier state may underlie the clinical findings in some older men diagnosed as having essential tremor.

Entities:  

Mesh:

Year:  2003        PMID: 12533098     DOI: 10.1001/archneur.60.1.117

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  36 in total

1.  FMR1 premutation as a rare cause of late onset ataxia--evidence for FXTAS in female carriers.

Authors:  Ch Zühlke; A Budnik; U Gehlken; A Dalski; S Purmann; M Naumann; M Schmidt; K Bürk; E Schwinger
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

2.  No association between FMR1 premutations and multiple system atrophy.

Authors:  Ichiro Yabe; Hiroyuki Soma; Asako Takei; Naoto Fujik; Hidenao Sasaki
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

Review 3.  Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates.

Authors:  Jeremy D Schmahmann; Eric E Smith; Florian S Eichler; Christopher M Filley
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

4.  Clinically significant psychiatric symptoms among male carriers of the fragile X premutation, with and without FXTAS, and the mediating influence of executive functioning.

Authors:  Jim Grigsby; Angela G Brega; Rachael E Bennett; James A Bourgeois; Andreea L Seritan; Glenn K Goodrich; Randi J Hagerman
Journal:  Clin Neuropsychol       Date:  2016-06-29       Impact factor: 3.535

5.  FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.

Authors:  Lorena Santa María; Solange Aliaga; Víctor Faundes; Paulina Morales; Ángela Pugin; Bianca Curotto; Paula Soto; M Ignacia Peña; Isabel Salas; M Angélica Alliende
Journal:  Genet Res (Camb)       Date:  2016-06-28       Impact factor: 1.588

6.  Which approach is better: bilateral versus unilateral thalamic deep brain stimulation in patients with fragile X-associated tremor ataxia syndrome.

Authors:  R Mehanna; I Itin
Journal:  Cerebellum       Date:  2014-04       Impact factor: 3.847

Review 7.  Essential pitfalls in "essential" tremor.

Authors:  Alberto J Espay; Anthony E Lang; Roberto Erro; Aristide Merola; Alfonso Fasano; Alfredo Berardelli; Kailash P Bhatia
Journal:  Mov Disord       Date:  2017-01-24       Impact factor: 10.338

Review 8.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

9.  Argonaute2 suppresses Drosophila fragile X expression preventing neurogenesis and oogenesis defects.

Authors:  Anita S-R Pepper; Rebecca W Beerman; Balpreet Bhogal; Thomas A Jongens
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

Review 10.  Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management.

Authors:  Randi J Hagerman; Paul Hagerman
Journal:  Nat Rev Neurol       Date:  2016-06-24       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.